Terpenes with Antitumor Activity: A Patent Review

Author(s): Juliana de Vasconcelos Cerqueira Braz*, José Adão Carvalho Nascimento Júnior, Mairim Russo Serafini

Journal Name: Recent Patents on Anti-Cancer Drug Discovery

Volume 15 , Issue 4 , 2020


Become EABM
Become Reviewer
Call for Editor

Abstract:

Background: Cancer is a major public health concern, and is one of the leading causes of death globally. Surgical removal, chemotherapy or hormonal therapy, radiation therapy, or a combination of them are treatment for cancer, many of which are ineffective or have serious side effects. In view of this, there is a search for new, more effective alternatives for cancer prevention and treatment. One possible source of compounds are natural products; among them, terpenes, a large class of organic compounds, have shown promise due to their anti-inflammatory, anti-tumorigenic, and hypolipidemic properties, among others recorded in the literature.

Objective: The study aims to use a patent review to evaluate the development and use of terpenes, or formulations containing terpenes, in new therapeutic options for the treatment of various types of cancer.

Methods: This patent review was carried out using the specialized patent databases of WIPO and Espacenet. The selection of patents was based on the following inclusion criteria which included pre-clinical and/or clinical trials, and demonstrated anti-tumor effects.

Results: Eight patents were identified, six from China, and two from Japan. In this review, all patents confirmed having good antitumor activity for many types of cancer cells. In addition, the inventors indicate more studies pre-clinical and clinical trials giving greater clarity and accurate reflection of the activity of the products studied.

Conclusion: Natural products are an important source of compounds for use in the fight against cancer that can act synergistically, and help in the treatment of cancer.

Keywords: Antineoplastic, antitumor, cancer, chemotherapy, natural products, patents, terpene, therapy.

[1]
Avgerinos KI, Spyrou N, Mantzoros CS, Dalamaga M. Obesity and cancer risk: Emerging biological mechanisms and perspectives. Metabolism 2019; 92: 121-35.
[2]
Zugazagoitia J, Guedes C, Ponce S, Ferrer I, Molina-Pinelo S, Paz-Ares L. Current challenges in cancer treatment. Clin Ther 2016; 38(7): 1551-66.[http://dx.doi.org/10.1016/j.clinthera.2016.03.026] [PMID: 27158 009]
[3]
Russo A, Cardile V, Graziano ACE, et al. Antigrowth activity and induction of apoptosis in human melanoma cells by Drymis winteri forst extract and its active components. Chem Biol Interact 2019; 305: 79-85.[http://dx.doi.org/10.1016/j.cbi.2019.03.029] [PMID: 30935903]
[4]
Yuan R, Hou Y, Sun W, et al. Natural products to prevent drug resistance in cancer chemotherapy: A review. Ann N Y Acad Sci 2017; 1401(1): 19-27.[http://dx.doi.org/10.1111/nyas.13387] [PMID: 28891091]
[5]
World Health Organization. WHO report on cancer. 2020.
[6]
Fidler MM, Gupta S, Soerjomataram I, Ferlay J, Steliarova-Foucher E, Bray F. Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: A population-based study. Lancet Oncol 2017; 18(12): 1579-89.[http://dx.doi.org/10.1016/S1470-2045(17)30677-0] [PMID: 29111 259]
[7]
Cheong DHJ, Arfuso F, Sethi G, et al. Molecular targets and anti- cancer potential of ESCIN. Cancer Lett 2018; 422: 1-8.[http://dx.doi.org/10.1016/j.canlet.2018.02.027] [PMID: 29474858]
[8]
Gill BS, Kumar S, Navgeet. Triterpenes in cancer: Significance and their influence. Mol Biol Rep 2016; 43(9): 881-96.[http://dx.doi.org/10.1007/s11033-016-4032-9] [PMID: 27344437]
[9]
Ateba SB, Mvondo MA, Ngeu ST, et al. Natural terpenoids against female breast cancer: A 5-year recent research. Curr Med Chem 2018; 25(27): 3162-213.[http://dx.doi.org/10.2174/0929867325666180214110932] [PMID: 29446727]
[10]
Li Y, Li S, Meng X, Gan RY, Zhang JJ, Li HB. Bin. Dietary natural products for prevention and treatment of breast cancer. Nutrients 2017; 9(7): 1-38.[http://dx.doi.org/10.3390/nu9070728] [PMID: 28698459]
[11]
Zeineldin R. Cancer Nanotechnology Methods and Protocols. 1st ed. Humana Press: Totowa, NJ, USA, 2010. 1530: 247-54
[12]
Braicu C, Mehterov N, Vladimirov B, et al. Nutrigenomics in cancer: Revisiting the effects of natural compounds. Semin Cancer Biol 2017; 46: 84-106.[http://dx.doi.org/10.1016/j.semcancer.2017.06.011] [PMID: 286764 60]
[13]
Cui Q, Yang DH, Chen ZS. Special issue: Natural products: Anticancer and beyond. Molecules 2018; 23(6): 11-4.[http://dx.doi.org/10.3390/molecules23061246] [PMID: 29882875]
[14]
Davis MP. Cannabinoids for symptom management and cancer therapy: The evidence. J Natl Compr Canc Netw 2016; 14(7): 915-22.[http://dx.doi.org/10.6004/jnccn.2016.0094] [PMID: 27407130]
[15]
Śledziński P, Zeyland J, Słomski R, Nowak A. The current state and future perspectives of cannabinoids in cancer biology. Cancer Med 2018; 7(3): 765-75.[http://dx.doi.org/10.1002/cam4.1312] [PMID: 29473338]
[16]
Guimarães AG, Serafini MR, Quintans-Júnior LJ. Terpenes and derivatives as a new perspective for pain treatment: A patent review. Expert Opin Ther Pat 2014; 24(3): 243-65.[http://dx.doi.org/10.1517/13543776.2014.870154] [PMID: 243871 85]
[17]
Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod 2020; 83(3): 770-803.[http://dx.doi.org/10.1021/acs.jnatprod.9b01285] [PMID: 32162523]
[18]
Alves IA, Savi FM, de Vasconcelos C, Braz J. Quintans Junior LJ, Serafini MR. The patenting and technological trends in candidiasis treatment: A systematic review (2014-2018). Curr Top Med Chem 2019; 19(28): 2629-39.[http://dx.doi.org/10.2174/1568026619666191030091211] [PMID: 31670621]
[19]
Hammond GB, Fernández ID, Villegas LF, Vaisberg AJ. A survey of traditional medicinal plants from the Callejón de Huaylas, Department of Ancash, Perú. J Ethnopharmacol 1998; 61(1): 17-30.[http://dx.doi.org/10.1016/S0378-8741(98)00009-9] [PMID: 96870 78]
[20]
Rabi T, Bishayee A. Terpenoids and breast cancer chemoprevention. Breast Cancer Res Treat 2009; 115(2): 223-39.[http://dx.doi.org/10.1007/s10549-008-0118-y] [PMID: 18636327]
[21]
Yu X, Lin H, Wang Y, et al. d-limonene exhibits antitumor activity by inducing autophagy and apoptosis in lung cancer. OncoTargets Ther 2018; 11: 1833-47.[http://dx.doi.org/10.2147/OTT.S155716] [PMID: 29670359]
[22]
Chen B, Hou ZH, Dong Z, Li CD. Crocetin downregulates the proinflammatory cytokines in methylcholanthrene-induced rodent tumor model and inhibits COX-2 expression in cervical cancer cells. BioMed Res Int 2015; 2015: 829513.[http://dx.doi.org/10.1155/2015/829513] [PMID: 25874230]
[23]
Silva EAP, Carvalho JS, Guimarães AG, et al. The use of terpenes and derivatives as a new perspective for cardiovascular disease treatment: A patent review (2008-2018). Expert Opin Ther Pat 2019; 29(1): 43-53.[http://dx.doi.org/10.1080/13543776.2019.1558211] [PMID: 3058 3706]
[24]
Kozlov AM, Baryshnikov AU, Maganova FI, et al. Antitumor terpenoid pharmaceutical composition ampicillin exhibiting vascularization inhibitory action. JP20140162970, 2014.
[25]
Dasari S, Tchounwou PB. Cisplatin in cancer therapy: Molecular mechanisms of action. Eur J Pharmacol 2014; 740: 364-78.[http://dx.doi.org/10.1016/j.ejphar.2014.07.025] [PMID: 25058905]
[26]
Ho GY, Woodward N, Coward JIG. Cisplatin versus carboplatin: Comparative review of therapeutic management in solid malignancies. Crit Rev Oncol Hematol 2016; 102: 37-46.[http://dx.doi.org/10.1016/j.critrevonc.2016.03.014] [PMID: 27105 947]
[27]
Zhou J, Kang Y, Chen L, et al. The drug-resistance mechanisms of five platinum-based antitumor agents. Front Pharmacol 2020; 11: 343.[http://dx.doi.org/10.3389/fphar.2020.00343] [PMID: 32265714]
[28]
Souza MVN, Gonçalves RSB, Pinheiro AC, Ferreira MLL. Produtos naturais em fase avançada de testes clínicos no tratamento contra o câncer natural products in advance clinical trials applied to cancer. Rev Fitos 2007; 3: 25-42.
[29]
Alves RC, Fernandes RP, Eloy JO, Salgado HRN, Chorilli M. Characteristics, properties and analytical methods of paclitaxel: A review. Crit Rev Anal Chem 2018; 48(2): 110-8.[http://dx.doi.org/10.1080/10408347.2017.1416283] [PMID: 292396 59]
[30]
Kumar A, Jaitak V. Natural products as multidrug resistance modulators in cancer. Eur J Med Chem 2019; 176: 268-91.[http://dx.doi.org/10.1016/j.ejmech.2019.05.027] [PMID: 31103904]
[31]
Brandão HN, David JP, Couto RD, Nascimento JAP, David JM. Química e farmacologia de quimioterápicos antineoplásicos derivados de plantas. Quim Nova 2010; 33: 1359-69.[http://dx.doi.org/10.1590/S0100-40422010000600026]
[32]
Ifor DB, Ahmed YA. Anti-tumour terpene compounds. CN201010205334, 2010.
[33]
Bladt TT, Frisvad JC, Knudsen PB, Larsen TO. Anticancer and antifungal compounds from aspergillus, penicillium and other filamentous fungi. Molecules 2013; 18(9): 11338-76.[http://dx.doi.org/10.3390/molecules180911338] [PMID: 24064454]
[34]
Li C, Xiao H, Bingshuai W, Qiqingcn Z. Indole terpene speradine b derived from Aspergillus Oryzae and application. CN201410201914, 2014.
[35]
Li C, Xiao H, Ingshuai W, Qiqing Z. Indole terpene speradine e derived from Aspergillus oryzae and application. CN201410201856, 2014.
[36]
Li C, Xiao H, Bingshuai W, Qiqingcn Z. Indole terpene speradine F derived from Aspergillus oryzae. CN201410202318, 2014.
[37]
Li C, Xiao H, Bingshuai W, Qiqingcn Z. Indole terpene speradine H derived from Aspergillus oryzae and application. CN201410202192, 2014.
[38]
Kobayashi J, Komaki H, Mikami N, Nemoto A, Tanaka T, Yazawa K. New Terpene-based compound 0406tp-1. JP19970261106, 1997.
[39]
Zhang X-W, Yang L, An L, Li P, Chen J. Discovery of cancer cell proliferation inhibitors from Salviae miltiorrhizae radix et rhizoma by a trace peak enrichment approach. J Sep Sci 2019; 42(2): 534-46.[http://dx.doi.org/10.1002/jssc.201800895] [PMID: 30414239]
[40]
Shen L, Lou Z, Zhang G, Xu G, Zhang G. Diterpenoid Tanshinones, the extract from Danshen (Radix Salviae miltiorrhizae) induced apoptosis in nine human cancer cell lines. J Tradit Chin Med 2016; 36: 514-21.
[41]
Donghua J. Novel Medical application of radix Salviae miltiorrhizae terpene ether. CN110934861, 2020.
[42]
Rayan A, Raiyn J, Falah M. Nature is the best source of anticancer drugs: Indexing natural products for their anticancer bioactivity. PLoS One 2017; 12(11): e0187925.[http://dx.doi.org/10.1371/journal.pone.0187925] [PMID: 29121120]
[43]
Sezer ED, Oktay LM, Karadadaş E, Memmedov H, Selvi Gunel N, Sözmen E. Assessing anticancer potential of blueberry flavonoids, quercetin, kaempferol, and gentisic acid, through oxidative stress and apoptosis parameters on HCT-116 cells. J Med Food 2019; 22(11): 1118-26.[http://dx.doi.org/10.1089/jmf.2019.0098] [PMID: 31241392]
[44]
Anwar S, Almatroudi A, Alsahli MA, Khan MA, Khan AA, Rahmani AH. Natural products: Implication in cancer prevention and treatment through modulating various biological activities. Anticancer Agents Med Chem 2020; 20(17): 2025-40.[http://dx.doi.org/10.2174/1871520620666200705220307] [PMID: 32628596]
[45]
Sun W, Shi Q, Zhang H, et al. Advances in the techniques and methodologies of cancer gene therapy. Discov Med 2019; 27(146): 45-55.[PMID: 30721651]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 15
ISSUE: 4
Year: 2020
Page: [321 - 328]
Pages: 8
DOI: 10.2174/1574892815666201002162315
Price: $65

Article Metrics

PDF: 33
HTML: 4
EPUB: 1
PRC: 1